A significant increase in animal farming has led to a rise in demand for animal health services for the improvement of food safety systems and veterinary public health in order to safeguard human health. The adoption of animal healthcare services is highly dependent on the fiscal, political, and institutional factors of the country.
A significant increase in animal farming has led to a rise in demand for animal health services for the improvement of food safety systems and veterinary public health in order to safeguard human health. The adoption of animal healthcare services is highly dependent on the fiscal, political, and institutional factors of the country.
In order to increase the adoption of animal health services, governments directly take part by increasing awareness among the general population regarding animal diseases and the privatization of animal healthcare services.
One such scheme in Europe is Livestock Insurance, which was implemented to increase the effectiveness and efficiency of animal healthcare systems. Another case that can be considered is of the U.K. government compensating direct losses incurring owing to the outbreaks from the EU compensation schemes and the U.K. national budget.
Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/2882
The companies are focusing on outsourcing the manufacturing of animal healthcare products in order to reduce their manufacturing costs and also compete in the market with reduced prices. Some of the leading companies operating in the global animal healthcare market are Bayer AG, Boehringer Ingelheim GmbH, Virbac S.A., Zoetis, Inc., Hester Biosciences Ltd., and Intas Pharmaceuticals Ltd. Animal healthcare providers, on the other hand, are leveling up the game with the implementation of various strategies. Manufacturers are focused on developing new products to increase the acceptance of Animal Healthcare, thus expecting to increase their respective market shares.
According to a report published by Persistence Market Research (PMR), the global animal healthcare market is expected to witness a CAGR of 4.8% from 2017 to 2025. In 2017, the market was worth US$ 30,744.2 Mn and is estimated to rise to a valuation of US$ 44,847.2 Mn by the end of 2025.
Rising Prevalence of Contagious Diseases to Accelerate Adoption of Animal Healthcare
Animals are more susceptible to a wide range of contagious diseases such as Peste des petits ruminants, foot-and-mouth disease, bovine pleuropneumonia, Newcastle disease, classical and African swine fever, and influenza (particularly equine and avian influenza), among others, through direct or indirect contact.
Peste des petits ruminants (PPR) or goat plague is a highly contagious disease that generally affects small ruminants. According to the Food and Agricultural Organization, the PPR virus can infect up to 90% of the small ruminant population and can even result in deaths of 30–70% of the animal population.
The continuous outbreaks of contagious diseases can severely impact the production of livestock, resulting in direct & indirect economic losses. Besides, significant resources are required to control the disease outbreak.
Owing to the aforesaid reasons, the government organizations along with public organizations have shared financial resources to prevent and control the contagious disease in livestock animals and it is expected to fuel the growth of the global animal healthcare market during the forecast period.
Request for Customization Here @ https://www.persistencemarketresearch.com/request-customization/2882
Use of Counterfeit Medicines to Hinder Market Growth
Mounting concerns over the provision of illicit drugs in developing and under-developed countries are expected to restrain the growth of the animal healthcare market. Illegal drugs are unregistered and falsified, counterfeit products, and unapproved parallel imports.
This also includes illegal autogenous vaccines and compounded pharmaceuticals. These products are not manufactured or used appropriately in accordance with regulations. The risk of illegal medicines is not only due to lack of efficacy and safety of animals but they also affect the sale of approved drugs.
The use of counterfeit medicines for animal health, which is usually cheap and of low quality, has a strong negative impact on the branded drugs market. The trend of counterfeit medicines is more commonly seen in under-developed and developing countries and as a result, the demand for the approved medicines witness a decline.
For In-Depth Competitive Analysis, Buy now @ https://www.persistencemarketresearch.com/checkout/2882
Company Profile
- Bayer AG
- Alvira Animal Health Limited
- Vetoquinol S.A.
- Zydus Animal Health
- Norbrook Laboratories Limited
- Phibro Animal Health Corporation
- Dechra Pharmaceuticals PLC Norbrook Laboratories, Inc
- Boehringer Ingelheim GmbH
- Virbac SA
- Zoetis, Inc.
- Hester Biosciences Ltd.
- Intas Pharmaceuticals Ltd.
- Overview
- Merck Animal Health
- Elanco (Eli Lilly and Company)
- Ceva Santé Animale
- Others
More about the Life Sciences & Transformational Health –
Unprecedented access to a world of information has given rise to the empowered, albeit distrustful, consumer. So is the case with healthcare, where the patient has been rendered more informed and conscientious thanks to the extraordinary penetration of the Internet. The discerning patient now demands more affordable, sophisticated, transparent, and personalized healthcare services, creating the need for new models for care.
The advent of health information technology (HIT) components such as electronic health records (EHR), hospital information systems (HIS), picture archiving and communication systems (PACS), and vendor-neutral archives (VNA) has had just as transformational an impact on the overall healthcare sector as the concerns regarding security and privacy. Data theft, undue access to personal health records, and cyber-attacks are very real threats that the healthcare sector faces today.
Get Similar Articles
Oesophageal Cancer Diagnostics Market –
The key participants operating in the global oesophageal cancer diagnostics market are: Cernostics, CDx Diagnostics, Inc., Creative Diagnostics, NeoGenomics Laboratories, Inc., BioIVT, Advanced Cell Diagnostics Inc. and others. For More Information
Mass Notification Systems In Healthcare Market - Mass Notification Systems In Healthcare Market segmentations by key players - AtHoc, Inc., Desktop Alert, Inc., Eaton Corporation, Emergency Communications Network, Everbridge, Inc., Honeywell International, Inc., Lone Star Communications, Inc., Metis Secure Solutions, MIR3, and Siemens AG. For More Information.
About us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Contact us:
305 Broadway, 7th Floor
New York City, NY 10007
United States
Ph.no. +1-646-568-7751
E-mail id– sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com